114 related articles for article (PubMed ID: 5901332)
1. Use of a new antimicrobial otic solution. MONEX in the treatment of external otitis.
Pavelic RA; Daly JF
Eye Ear Nose Throat Mon; 1966 Jan; 45(1):52-6. PubMed ID: 5901332
[No Abstract] [Full Text] [Related]
2. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.
Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P
J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571
[TBL] [Abstract][Full Text] [Related]
3. Otitis externa.
Hajioff D
Clin Evid; 2003 Dec; (10):605-11. PubMed ID: 15555110
[No Abstract] [Full Text] [Related]
4. Efficacy of ofloxacin and other otic preparations for otitis externa.
Ruben RJ
Pediatr Infect Dis J; 2001 Jan; 20(1):108-10; discussion 120-2. PubMed ID: 11176588
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic criteria and therapy of malignant external otitis].
Crovetto de la Torre MA; Fiz Melsio L; Grande Icaran D
Acta Otorrinolaringol Esp; 1996; 47(3):175-80. PubMed ID: 8924279
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature.
Wall GM; Stroman DW; Roland PS; Dohar J
Pediatr Infect Dis J; 2009 Feb; 28(2):141-4. PubMed ID: 19116600
[TBL] [Abstract][Full Text] [Related]
7. Use of a new drug for effective management of otitis externa in small animals.
Tanzer H
Vet Med Small Anim Clin; 1971 Nov; 66(11):1082 passim. PubMed ID: 5209413
[No Abstract] [Full Text] [Related]
8. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
9. The use of topical ofloxacin for otic diseases in infants and children. Summary and conclusions.
Klein JO; McCracken GH
Pediatr Infect Dis J; 2001 Jan; 20(1):123-5. PubMed ID: 11176592
[No Abstract] [Full Text] [Related]
10. Oral fluoroquinolones for malignant external otitis.
Misch S
Am Fam Physician; 1994 Jun; 49(8):1729-30. PubMed ID: 8203311
[No Abstract] [Full Text] [Related]
11. Otitis externa.
Long M
Pediatr Rev; 2013 Mar; 34(3):143-4. PubMed ID: 23457202
[No Abstract] [Full Text] [Related]
12. Medical therapy of otitis externa and otitis media.
Morris DO
Vet Clin North Am Small Anim Pract; 2004 Mar; 34(2):541-55, vii-viii. PubMed ID: 15062623
[TBL] [Abstract][Full Text] [Related]
13. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study.
Supiyaphun P; Tonsakulrungruang K; Chochaipanichnon L; Chongtateong A; Samart Y
J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972
[TBL] [Abstract][Full Text] [Related]
14. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa.
Berenholz L; Katzenell U; Harell M
Laryngoscope; 2002 Sep; 112(9):1619-22. PubMed ID: 12352675
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment for otorrhea: issues and controversies.
Bance M; Rutka JA
J Otolaryngol; 2005 Aug; 34 Suppl 2():S52-5. PubMed ID: 16076416
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
17. Diffuse external otitis--treatment of 175 ears with a new preparation (Synalar Otic).
Fields JA; Benton CD
Eye Ear Nose Throat Mon; 1969 May; 48(5):298-300. PubMed ID: 4305310
[No Abstract] [Full Text] [Related]
18. Otitis externa: a clinical overview.
Schapowal A
Ear Nose Throat J; 2002 Aug; 81(8 Suppl 1):21-2. PubMed ID: 12199185
[No Abstract] [Full Text] [Related]
19. Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD; Kelbick NT
Vet Dermatol; 2006 Apr; 17(2):128-33. PubMed ID: 16515655
[TBL] [Abstract][Full Text] [Related]
20. Otitis externa: Review and clinical update.
Osguthorpe JD; Nielsen DR
Am Fam Physician; 2006 Nov; 74(9):1510-6. PubMed ID: 17111889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
